Trends in the pharmacological treatment of benign prostatic hyperplasia in the UK from 1998 to 2016: a population-based cohort study.

Henok Tadesse AyelePauline ReynierLaurent Azoulay Robert W PlattJosselin CabausselSerge BenayounKristian B Filion

Published in: World journal of urology (2020)

The prescription rate of BPH medications increased substantially between 1998 and 2016 in the UK, with the greatest relative increase observed with combination therapy. Adherence to BPH medications was low in this population-based study.

Keyphrases

benign prostatic hyperplasia
combination therapy
lower urinary tract symptoms
cross sectional
type diabetes
adipose tissue